Urban Public Health Department, Manning College of Nursing and Health Sciences, University of Massachusetts Boston, 100 Morrissey Blvd, Boston, MA, USA.
School of Nursing, MGH Institute for Health Professions, Charleston, MA, USA.
BMC Public Health. 2024 Nov 7;24(1):3075. doi: 10.1186/s12889-024-20522-9.
While TB-related mortality in the US declined four-fold from 1990 to 2019, country-level estimates of TB burden obscure within-state racial heterogeneity and changes in TB burden over time. In sixteen US Southern States and Washington DC, the effects of health inequities engendered by Jim-Crow laws enacted from the late 1800s to the 1960s have not been evaluated for TB-related mortality. We, therefore, sought to compare TB mortality rates and annualized rate of change (AROC) between 1990 and 2019 in former Jim-Crow vs. non-Jim-Crow states to help guide response efforts and inform resource prioritization to improve racial equity.
We evaluated whether TB-related mortality varied over time, from 1990 to 2019, between states that have a history of enacting Jim-Crow laws vs. states with no such history using estimates from the Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019). TB mortality per 100,000 population and bootstrap 95% uncertainty intervals (UIs) were modeled using the Cause of Death Ensemble model (CODEm) framework with varying combinations of predictive covariates. For changes over time, we present age-standardized AROC as the percent difference in the natural logarithm of the rate in 1990 and 2019 divided by 30 (i.e., 100*[ln(2019 Rate/1990 Rate)/(30)) and the corresponding 95% UIs.
TB-related mortality in all US states declined between 1990 and 2019. From 1990 to 2019, most former Jim-Crow states had higher mortality rates than states that did not enact Jim-Crow laws. The most significant decline in TB mortality was in Washington DC, with a six-fold decline from 2.69 (2.46-2.96) per 100,000 population in 1990 to 0.45(0.37-0.55) in 2019, corresponding to an AROC of -0.83% (-0.86;-0.79). The lowest decline was in Iowa, from 0.30 (0.27-0.33) to 0.09 (0.07-0.11) (AROC: -0.70% (-0.76; -0.63)). Eleven of the 16 states and Washington DC in the third tertile of TB mortality rate in 1990 (range 0.81-2.69) had a history of Jim-Crow laws, whereas none of the 17 states in the first tertile (range 0.30-0.51) had such history. Conversely, mortality decreased relatively slowly in former Jim-Crow states than in non-Jim-Crow states.
Even though the 1964 Civil Rights Act dismantled Jim-Crow statutes, racial inequities in TB burden experienced by past generations may still be felt in subsequent generations. Understanding the role of structural racism at the intersection of science and medicine shows the complex ways historical laws, such as Jim-Crow laws, continue to negatively impact health outcomes and warn of future dangers, such as COVID-19, to avoid.
尽管美国的结核病相关死亡率从 1990 年到 2019 年下降了四倍,但国家层面的结核病负担估计掩盖了州内的种族差异和随着时间的推移结核病负担的变化。在 16 个美国南部州和华盛顿特区,自 19 世纪末至 20 世纪 60 年代颁布的《吉姆·克劳法》所产生的健康不平等的影响尚未针对结核病相关死亡率进行评估。因此,我们试图比较前吉姆·克劳州和非吉姆·克劳州之间 1990 年至 2019 年的结核病死亡率和年变化率(AROC),以帮助指导应对工作,并为改善种族公平提供资源优先排序的信息。
我们使用 2019 年全球疾病、伤害和危险因素研究(GBD 2019)的数据,评估了从 1990 年到 2019 年,在有颁布吉姆·克劳法历史的州与没有这种历史的州之间,结核病相关死亡率是否随时间变化。使用死因综合模型(CODEm)框架,根据不同的预测性协变量组合,对每 10 万人中的结核病死亡率和 bootstrap 95%置信区间(UI)进行建模。对于随时间的变化,我们以年龄标准化的 AROC 表示,即 1990 年和 2019 年的比率自然对数的差异除以 30(即 100*[ln(2019 年的比率/1990 年的比率)/(30)]),并给出相应的 95%UI。
1990 年至 2019 年间,美国所有州的结核病相关死亡率均有所下降。从 1990 年到 2019 年,大多数前吉姆·克劳州的死亡率高于没有颁布吉姆·克劳法的州。结核病死亡率下降最显著的是华盛顿特区,从 1990 年的每 10 万人 2.69(2.46-2.96)下降到 2019 年的 0.45(0.37-0.55),相应的 AROC 为-0.83%(-0.86;-0.79)。下降幅度最小的是爱荷华州,从 0.30(0.27-0.33)降至 0.09(0.07-0.11)(AROC:-0.70%(-0.76;-0.63))。在 1990 年结核病死亡率处于第三 tertile(范围为 0.81-2.69)的 16 个州和华盛顿特区中,有 11 个州和华盛顿特区有颁布吉姆·克劳法的历史,而在 17 个处于第一 tertile(范围为 0.30-0.51)的州中,没有任何州有这种历史。相反,前吉姆·克劳州的死亡率下降速度比非吉姆·克劳州慢。
尽管 1964 年的《民权法案》废除了《吉姆·克劳法》,但过去几代人在结核病负担方面经历的种族不平等可能仍会影响到后代。了解科学和医学交叉点的结构性种族主义的作用表明,历史法律(如吉姆·克劳法)继续对健康结果产生负面影响,并警告未来可能出现的危险,如 COVID-19,以避免这些危险。